Skip to main content
TipRanks
Go Ultimate75% OFF

AFT Pharmaceuticals Ltd. (AFT) Stock Statistics & Valuation Metrics

Total Valuation

AFT Pharmaceuticals Ltd. has a market cap or net worth of NZD 483.47M. The enterprise value is NZD 395.00M.

Market Cap
NZD 483.47M
Enterprise Value
NZD 395.00M

Share Statistics

AFT Pharmaceuticals Ltd. has 104,874,660 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
104,874,660
Owned by Insiders
―
Owned by Institutions
0.05%

Financial Efficiency

AFT Pharmaceuticals Ltd.’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 9.80%.

Return on Equity (ROE)
0.13
Return on Assets (ROA)
0.07
Return on Invested Capital (ROIC)
9.80%
Return on Capital Employed (ROCE)
0.16
Revenue Per Employee
2.02M
Profits Per Employee
116.90K
Employee Count
126
Asset Turnover
1.17
Inventory Turnover
1.95

Valuation Ratios

The current PE Ratio of AFT Pharmaceuticals Ltd. is 32.67. AFT Pharmaceuticals Ltd.’s PEG ratio is 1.96.

PE Ratio
32.67
PS Ratio
1.90
PB Ratio
4.39
Price to FCF
-40.83
Price to Operating Cash Flow
-41.23
PEG Ratio
1.96

Income Statement

In the last 12 months, AFT Pharmaceuticals Ltd. had revenue of 254.71M and earned 14.73M in profits. Earnings per share was 0.14.

Revenue
254.71M
Gross Profit
110.55M
Operating Income
24.86M
Pretax Income
21.87M
Net Income
14.73M
EBITDA
28.55M
Earnings Per Share (EPS)
0.14

Cash Flow

In the last 12 months, operating cash flow was -11.75M and capital expenditures -116,000, giving a free cash flow of -11.87M billion.

Operating Cash Flow
-11.75M
Free Cash Flow
-11.87M
Free Cash Flow per Share
-0.11

Dividends & Yields

AFT Pharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of 0.64%

Dividend Per Share
―
Dividend Yield
0.64%
Payout Ratio
N/A
Free Cash Flow Yield
-2.45%
Earnings Yield
3.05%

Stock Price Statistics

Beta
-0.08
52-Week Price Change
45.89%
50-Day Moving Average
4.46
200-Day Moving Average
3.98
Relative Strength Index (RSI)
50.96
Average Volume (3m)
20.57K

Important Dates

AFT Pharmaceuticals Ltd. upcoming earnings date is Nov 26, 2026, Before Open (Not Confirmed).

Last Earnings Date
May 20, 2026
Next Earnings Date
Nov 26, 2026
Ex-Dividend Date
―

Financial Position

AFT Pharmaceuticals Ltd. as a current ratio of 2.24, with Debt / Equity ratio of 49.06%

Current Ratio
2.24
Quick Ratio
1.12
Debt to Market Cap
0.14
Net Debt to EBITDA
1.54
Interest Coverage Ratio
9.98

Taxes

In the past 12 months, AFT Pharmaceuticals Ltd. has paid 7.79M in taxes.

Income Tax
7.79M
Effective Tax Rate
0.36

Enterprise Valuation

AFT Pharmaceuticals Ltd. EV to EBITDA ratio is 18.28, with an EV/FCF ratio of -44.44.

EV to Sales
2.07
EV to EBITDA
18.28
EV to Free Cash Flow
-44.44
EV to Operating Cash Flow
-44.88

Balance Sheet

AFT Pharmaceuticals Ltd. has NZD 10.24M in cash and marketable securities with NZD 54.11M in debt, giving a net cash position of -NZD 43.87M billion.

Cash & Marketable Securities
NZD 10.24M
Total Debt
NZD 54.11M
Net Cash
-NZD 43.87M
Net Cash Per Share
-NZD 0.42
Tangible Book Value Per Share
NZD 0.43

Margins

Gross margin is 43.40%, with operating margin of 9.76%, and net profit margin of 5.78%.

Gross Margin
43.40%
Operating Margin
9.76%
Pretax Margin
8.59%
Net Profit Margin
5.78%
EBITDA Margin
11.33%
EBIT Margin
9.87%

Analyst Forecast

The average price target for AFT Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
―
Price Target Upside
―
Analyst Consensus
Moderate Buy
Analyst Count
1
Revenue Growth Forecast
22.44%
EPS Growth Forecast
23.14%

Scores

Smart Score
―
AI Score
54